Trial Profile
A randomised phase II study of S-1-based concurrent chemoradiotherapy in patients with biliary tract cancer.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Biliary cancer
- Focus Therapeutic Use
- 17 Dec 2015 New trial record